Synonyms:
Status: Phase 2
Entry Type: Antibody
UNII: B59DCD0F7D

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Delta-like protein 4 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109385
FDA SRS B59DCD0F7D